http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103417523-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3520aef4f4f2b4315bc62e839557171e |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 |
| filingDate | 2013-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44d45c1697560749e2844cf778d48eed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5abe4d5d0ac9667b402189ee5c69e4f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7f8bc76ebf3701ab3ba59eafe5b0150 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2b6a4894b3cca65717c91081293c16c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55709c65d6db3227e2534e31472106e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a25f351f1dd7ac1af873a20a8afc851f |
| publicationDate | 2015-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103417523-B |
| titleOfInvention | Application of L-glutamine to preparation of drug for treating high homocysteine |
| abstract | The invention discloses an application of L-glutamine to the preparation of a drug for treating high homocysteine, and relates to the technical field of medical drugs. The drug is a common amino acid, and has the following advantages when used for treating homocysteine compared with the universal drug clinically and frequently used for treating homocysteinemia: firstly, the curative effect, particularly the effect of directly reducing homocysteine in serum is remarkable; secondly, the safety is high, and no toxic and side effects exist; thirdly, economical load of patients can be reduced as the drug is obviously cheaper compared with the effective drugs frequently used or reported in the market at present; fourthly, the drug can be combined with other drugs for treatment as a compound preparation; fifthly, the drug can directly reduce the content of homocysteine in blood while remarkably reducing inflammatory reaction, thereby improving the oxidation resistance of the organism. |
| priorityDate | 2013-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 214.